SLE vs ETSU CPG

SLE-VTE score is a clinical prediction model to help physicians and researchers predict the risk of venous thromboembolism (VTE) in systemic lupus erythematosus (SLE) patients. This model is built and validated based on the Chinese SLE Treatment and Research group cohort (CSTAR). Logistic regression and least absolute shrinkage and selection operator were used to fit the model. The final prediction model (SLE-VTE score) included 11 variables: gender, age, body mass index (BMI), hyperlipidemia, hypoalbuminemia, C-reactive protein (CRP), anti-β2-glycoprotein 1 antibody, lupus anticoagulant, nervous system involvement, renal involvement, and hydroxychloroquine usage. We hope and welcome more cohorts to further validate and improve this model

The CPG lists guidelines and evidence for Distal Radius Fracture (DRF) , Carpal Tunnel, and Lateral Elbow Pain treatment. It covers prognosis, examination measures, and intervention (follow-up) methods. Our app provides recommendations to clinical practitioners based on the document. It allows them to input contextual information and then receive customized guidelines for each area: prognosis, examination, and intervention. The overall business goals are to improve the efficiency and accuracy of the treatment process, reducing health care costs.